Answers are grounded in this paper and cite their sources.
Objective: To determine the frequency and temporal trend of cytomegalovirus (CMV) DNA positivity detected by real-time polymerase chain reaction (PCR) in intestinal tissue and to identify associated demographic and clinical factors at a tertiary care center. Methods: All intestinal tissue CMV DNA real-time PCR requests finalized between January 1, 2020, and December 31, 2025, were retrospectively reviewed. Age, sex, requesting department, presumptive diagnosis, and PCR results were recorded. Temporal trends were assessed using the Cochran-Armitage trend test, and independently associated factors were evaluated using multivariable logistic regression. Results: Of 697 intestinal tissue samples, 126 (18.1%) were positive for CMV DNA. Patients with positive results were older than those with negative results (median age, 45 vs 27 years; P < .001). Positivity was higher in adults than in pediatric patients (21.4% vs 10.6%; P < .001) and in patients with inflammatory bowel disease (IBD) than in those without IBD (23.7% vs 15.9%; P = .02). The annual positivity rate increased from 10.5% in 2020 to 27.8% in 2025 (P < .001 for trend). In multivariable analysis, older age (adjusted odds ratio [OR], 1.31 per 10-year increase; 95% CI, 1.19-1.44), IBD diagnosis (adjusted OR, 2.24; 95% CI, 1.44-3.47), and calendar year (adjusted OR, 1.31 per 1-year increase; 95% CI, 1.13-1.53) were independently associated with tissue CMV DNA positivity. Conclusions: Tissue CMV DNA positivity increased over the 6-year study period and was independently associated with older age and IBD diagnosis. Because PCR positivity alone cannot distinguish latent or bystander viral detection from tissue-invasive disease, findings require histopathological and clinical correlation.
No takes yet. Share an insight, caveat, or question.
Zeybek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: